CNPR Pharmaceutical Sales Techniques & Strategies 4 — Questions and Answers
Question 1: When handling a safety objection about a side effect, the most appropriate first step is to:
- Minimize the side effect by comparing it to a competitor's profile
- Acknowledge the concern, then provide clinical context from the approved label (Correct answer)
- Promise to get back to the physician with more data next visit
- Redirect the conversation to efficacy data immediately
Correct answer: Acknowledge the concern, then provide clinical context from the approved label
Acknowledging the physician's concern builds trust before contextualizing the side effect with accurate, label-approved clinical information.
Question 2: A pharmaceutical rep's territory business plan (TBP) should primarily be driven by:
- Personal sales goals set by the rep independently
- Insights from customer data, market analysis, and strategic company objectives (Correct answer)
- The number of samples available for distribution
- Instructions from the medical affairs team only
Correct answer: Insights from customer data, market analysis, and strategic company objectives
An effective TBP integrates customer insights, market data, and corporate strategy to prioritize accounts and allocate resources optimally.
Question 3: What is the significance of 'decile ranking' in pharmaceutical sales targeting?
- It measures a rep's performance relative to peers
- It ranks physicians by prescription volume to prioritize the most impactful targets (Correct answer)
- It ranks drugs by insurance coverage tier
- It measures patient adherence rates by zip code
Correct answer: It ranks physicians by prescription volume to prioritize the most impactful targets
Decile ranking stratifies physicians into groups by prescribing volume, helping reps focus time on highest-potential targets.
Question 4: During a lunch-and-learn for a group of nurses and physicians, the rep should ensure the content is:
- Primarily focused on patient co-pay cards and savings programs
- Fair, balanced, and limited to FDA-approved indications and information (Correct answer)
- Focused on competitor weaknesses to distinguish the product
- Designed to generate immediate prescription commitments
Correct answer: Fair, balanced, and limited to FDA-approved indications and information
All educational programs sponsored by pharma companies must present fair and balanced information consistent with FDA-approved labeling.
Question 5: Which questioning technique is most effective for uncovering a physician's unmet clinical needs?
- Closed-ended questions for efficiency
- Leading questions to guide the physician toward your product
- Open-ended probing questions that allow elaboration (Correct answer)
- Rhetorical questions to make a point about efficacy
Correct answer: Open-ended probing questions that allow elaboration
Open-ended probing questions encourage physicians to share their clinical challenges, revealing opportunities where your product can provide solutions.
Question 6: A rep's call frequency on a specific physician should be adjusted based on:
- The rep's personal schedule and convenience
- The physician's prescribing potential, receptivity, and stage in the adoption cycle (Correct answer)
- How many samples the physician has requested historically
- The distance from the rep's home office
Correct answer: The physician's prescribing potential, receptivity, and stage in the adoption cycle
Optimal call frequency balances the physician's prescribing potential, their openness to visits, and where they are in adopting your product.
Question 7: What does PDCA stand for in the context of pharmaceutical sales performance improvement?
- Physician Data, Clinical Assessment
- Plan, Do, Check, Act (Correct answer)
- Product Detail, Customer Approach
- Prescriber Development Cycle Assessment
Correct answer: Plan, Do, Check, Act
PDCA is a continuous improvement cycle: Plan an action, Do it, Check results, and Act to refine the approach.
When handling a safety objection about a side effect, the most appropriate first step is to: